
DiaMedica Named 2011 Emerging Company of the Year by Life Science Association of Manitoba
The Emerging Life Science Company of the Year award celebrates a company based in Manitoba that is recognized for their growth potential.
The Emerging Life Science Company of the Year award celebrates a company based in Manitoba that is recognized for their growth potential.
The LSAM Awards Gala was held on October 5, 2011 at the Hotel Fort Garry. Click on the link for a full list of this year’s winners.
IMRIS announced that the first published results on the early clinical experiences at hospitals using the IMRIS system, highlight a number of positive findings for procedures and patient outcomes resulting from utilization of the intraoperative MRI capabi
Miraculins announced that it has completed an Exclusive Manufacturing and Supply Agreement with Thermo Fisher Scientific Inc.
Ag-West Bio leads study to evaluate feasibility of developing crops and processing for bio-jet fuels
Information on the Demonstration and Research and Development funding program Presented by Marc D’Iorio
Theo Wigle, a grade 12 student at Winnipeg’s Shaftesbury High School, was the winner of the 2011 Biotechnology Brain Game
Close to 20 positions have been eliminated from the National Research Council's operations in Winnipeg.
The board of Cold-FX flu remedy maker Afexa Life Sciences Inc. has given its final stamp of approval to a friendly $76-million takeover bid by Valeant Pharmaceuticals International Inc.
IMRIS announced the sale of two systems to a single confidential U.S. customer.
Kane Biotech Inc. is pleased to announce the invention and patenting of a new bone tissue regenerating fusion peptide based on the Company’s competence stimulating peptide oral care technology.
New opportunities for flax producers are firing up with the help of a Government of Canada investment. Flax Power has received more than $87,000 to help increase its production capacity, including the purchase and installation of new production equipment
Conviron president and CEO Steven Kroft told the exchange students while there are challenges associated with global trading, the payoffs can be huge.
Cangene Corporation announced that its board of directors has unanimously appointed John A. Sedor as president and chief executive officer.
IMRIS Inc.announced that it has received a Health Canada medical device license for AccuTrack™ the Company’s 3D image guidance tool for use in IMRIS neurosurgery suites.
A new study, in partnership between The Richardson Centre for Functional Foods and Nutraceuticals and St. Luke's-Roosevelt Hospital, has found a link between weight gain and sleep deprivation.
The first Canadian installation is being tested in Barrie, Ont. The second and third Canadian sales may happen before the end of the year.
The Canadian Innovation Commercialization Program (CICP) is a new, $40 million procurement program, launched as part of the Government of Canada’s commitment to promote Canada’s economic growth as announced in Budget 2010.
Two Winnipeg biotech firms braved the challenging capital markets this week in attempts to raise important development funds.
The Canada-Israel Industrial R&D Foundation (CIIRDF) is pleased to invite Canadian and Israeli companies to submit new joint R&D project proposals for funding.
DiaMedica is pleased to announce the completion today of its previously announced short form prospectus offering.
As part of the Global Biotech Week 2023 celebrations, BAM is not only celebrating the success stories within Manitoba's thriving $9.9 billion biotech industry but also taking a significant step towards securing its future.
Newly launched MY Sleep Scoring API provides free access to leading sleep analysis metric, accelerating research into the clinical management of disrupted sleep.
Provinces and territories will have access to updated COVID-19 vaccines for their respective fall vaccination campaigns
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.